Urologic Oncologist @cityofhope @cityofhopeoc
Irvine, CA
Joined March 2020
- Tweets126
- Following496
- Followers616
- Likes695
Alex Zhu retweeted
The BURN trial 🔥
@alexzhuDO shows buffered local reduces pain during prostate biopsy
@auawest #WSAUA26
Should we all be using buffered local for our pts?
👏
Really interesting trial in progress (PRESERVE trial) @UroAlsyouf @siadaneshmand @GU_BigWhacks
Randomizing patients 1:1 to facial sparing vs. standard inguinal orchiectomy. Endpoint = PRO’s
Personally have seen a difference in my own experience. Excited to see final results
Alex Zhu retweeted
What is the penetrance of urologic cancers in Lynch Syndrome?
Especially in MSH2 carriers, urologic cancers appear later than other Lynch-associated cancers - but become common after age 50.
From our @UrolOncol review on germline variants in urothelial cancer, using data from Prospective Lynch Syndrome Database. (plsd.eu/)
🧵
Alex Zhu retweeted
Meet BCAN Young Investigator Awardee @alexzhuDO
"Sometimes meaningful advances in cancer care come not only from discovering new treatments, but from learning how to use our existing treatments better. I am grateful for this award, which will support our research investigating whether optimizing the timing of BCG therapy can harness the body’s natural immune rhythms to improve outcomes for patients with NMIBC.”
ALT A portrait of Dr. Zhu. Next to the portrait, text reads: "Alexander Zhu, DO, 2026 Young Investigator Award Recipient." Below, a URL "bcan.org/research awards" appears, along with the BCAN logo and the text "Bladder Cancer Advocacy Network."
Alex Zhu retweeted
👏 Congratulations to our 15 Research Scholar Awardees!
The awardees are rising researchers advancing earlier detection, more personalized therapies and improved outcomes across urologic disease. This year’s awardees represent a diverse range of research areas—from cancer biology and artificial intelligence to pediatric care and infection prevention.
🔗 Click to learn more about the program and the awardees: bit.ly/4r5ABpA
Thank you so much to @SWOG and all my countless mentors for this incredible experience as the Vogelzang scholar over the past year!
I'm pretty sure @alexzhuDO blew everyone's mind with his #Vogelzang Scholar presentation at #SWOGSpring26. Citing work that he has done with a wide range of exceptional mentors (@spsutkaMD, @JLWrightMD, @PGrivasMDPhD, @wandering_gu, @UroCancer, @DanLinMD, @slernerbcmedu1, et al), he has achieved milestones as a fellow that I can only dream of as a full professor (e.g., enrollment of >300 pts in a single institution IST within 13 months).
Nick V. was the heart & soul of our @SWOG GU committee mtgs. I'm quite confident Nick would agree that Alex is the perfect person to receive an award bearing his name.
And Alex, welcome to @cityofhope!
Alex Zhu retweeted
So incredibly proud of @alexzhuDO presenting his #Vogelzang scholar lecture at #SWOG2026 - Alex is the ultimate clinical trialist, he takes real clinical problems and develops pragmatic trials with practice-changing impact.
Can’t wait to start at City of Hope in summer 2026. Excited to go back home, serve the patients in my community, and further strengthen the world class clinical trials division there!
@ClaytonLauMD @TDorffOnc @montypal @DrSCohen @WesleyYipMD
We are just head over heels that @alexzhuDO will be joining us at @cityofhopeoc! Will indeed be integrating him closely with our #kidneycancer research portfolio - already meeting with him regularly to ensure he will hit the ground running. Many thanks to @PGrivasMDPhD @DanLinMD @JLWrightMD @spsutkaMD @GoreJohn et al for the amazing training at @uwurology prior to his arrival at @cityofhope!
Alex Zhu retweeted
Looking forward/excited to have @alexzhuDO @uwurology joining @cityofhopeoc @CityofHopeSurg #Urology in Summer 2026. @ClaytonLauMD @COHurol @DrJeffYoshida @jyamzonmd @AliZUroOnc @WesleyYipMD @montypal #WSAUA25 @auawest
What motivates #BladderCancer patients to be active? A qualitative study assessing attitudes towards physical activity and digital health technologies. Presentation by @alexzhuDO @uwurology. #WSAUA25 written coverage by @zklaassen_md @GACancerCenter > bit.ly/4qDvJYj @auawest
Incredibly proud of @ApoorvDhir! What a huge accomplishment 🔥🔥
🎉 The @AmerUrological and the UCF are excited to recognize 12 researchers as recipients of the 2025 Urology Care Foundation Research Scholar Awards! This program has invested over $30 million to support over 675 Research Scholars!
Click to learn more 👉 bit.ly/48G1Iyn
Check out these additional papers
dailynews.ascopubs.org/do/pe…
@DSRoberson93 - data from Mayo of 28pt with EVP + consolidative Cx
sciencedirect.com/science/ar…
🙏🏻 to @BladderCancerUS for the JQTF award. And 100x thanks to @PGrivasMDPhD and Jonathan Wright my amazing mentors, for helping me design the TRIFECTA trial. This MIBC trial builds upon the NIAGARA regiment by adding nadofaragene to improve locoregional control. Launching soon!!
Thanks @shilpaonc @MaxKates et al.
Fantastic to be at #TT25 @BladderCancerUS excited to partner with stakeholders in our teamwork against #bladdercancer So proud of mentees who received JQTF award: @DRBakaloudiMD @alexzhuDO
Congrats to all awardees @AmandaMyersMD @Anto_cigliola
Alex Zhu retweeted
The future of bladder cancer is in great hands. 👏
Stellar class of 2025 John Quale Travel Fellows!
@BladderCancerUS #BCANTT25
Congratulations to all the 2025 John Quale Travel Fellows; and especially to our own @MDAndersonNews crew!
@AmandaMyersMD @Sood11
Comron Hassanzadeh
bcan.org/meet-the-john-quale… @BladderCancerUS @IBCG_BladderCA #BCANTT25 #OncSurgery
Alex Zhu retweeted
Congratulations to @alexzhuDO and @lisazxy080808! Dr. Zhu presented his research on the impact of arsenic levels on incident urologic cancers in Washington State, while Dr. Zhang discussed post-traumatic stress disorder in adults who underwent childhood voiding cystourethrogram (VCUG) testing. Well-deserved recognition for two outstanding presentations!
Great thread by @DrSpratticus on a topic I’ve been asked about by patients many times in the past week
15/x Summary:
- President Biden’s physician followed the current USPSTF recommendation to not perform PSA screening in men >70yo
- However, the USPSTF recommendations are flawed as PCa is common in men >70yo, is often more aggressive, if untreated men are more likely to die of PCa, and many men will live 15+ years.
- Focus should be on increased PSA screening, but reductions in over-dx and over-tx.
- Unfortunately, President Biden’s presentation is not uncommon in men >75yo diagnosed with PCa.
Get screened! @UHhospitals @RadOncUH
Grateful to have received the SWOG Genitourinary Scholarship. Named in honor of the late Dr. Vogelzang, it selects one early career investigator for longitudinal clinical trial mentorship
What an all 💫 group of mentors!!
@montypal
@UroCancer
@daniel_hamstra
